(19)
(11) EP 3 062 795 A1

(12)

(43) Date of publication:
07.09.2016 Bulletin 2016/36

(21) Application number: 14857110.2

(22) Date of filing: 03.11.2014
(51) International Patent Classification (IPC): 
A61K 31/497(2006.01)
A01N 43/54(2006.01)
(86) International application number:
PCT/US2014/063630
(87) International publication number:
WO 2015/066584 (07.05.2015 Gazette 2015/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 01.11.2013 US 201361898741 P
20.02.2014 US 201414184886

(71) Applicant: Kala Pharmaceuticals, Inc.
Waltham, MA 02453 (US)

(72) Inventors:
  • ENLOW, Elizabeth
    Waltham, Massachusetts 02451 (US)
  • NGUYEN, Minh Ngoc
    Dorchester, Massachusetts 02124 (US)
  • ONG, Winston Z.
    Stoneham, Massachusetts 02180 (US)

(74) Representative: Green, Mark Charles 
Urquhart-Dykes & Lord LLP The Podium 1 Eversholt Street
London NW1 2DN
London NW1 2DN (GB)

   


(54) CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF